AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2022
Nov 11, 2022
30870_dirs_2022-11-10_4cf05cb2-e709-4ee0-815a-8b7c1ff59dbe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-11-10
Reporting Person: Malik Fady Ibraham (EVP Research & Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-10 | Common Stock | S | 4000 | $38.04 | Disposed | 164346 | Direct |
Footnotes
F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18